BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
0.561
-0.024 (-4.12%)
At close: Dec 20, 2024, 4:00 PM
0.580
+0.019 (3.39%)
After-hours: Dec 20, 2024, 7:28 PM EST
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $25.53 million as of December 20, 2024. Its market cap has decreased by -67.40% in one year.
Market Cap
25.53M
Enterprise Value
19.59M
1-Year Change
-67.40%
Ranking
Category
Stock Price
$0.56
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has decreased from $26.00M to $25.53M, a decrease of -1.82%. That is a compound annual growth rate of -0.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 24.80M | -73.48% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LAVA Therapeutics | 27.09M |
| Pluri | 26.79M |
| NeuroSense Therapeutics | 26.48M |
| Calidi Biotherapeutics | 26.27M |
| Cognition Therapeutics | 26.18M |
| Curis | 26.08M |
| Lipocine | 26.04M |
| AEON Biopharma | 25.98M |